Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.4.22.69 extracted from

  • Mukherjee, P.; Desai, P.; Ross, L.; White, E.L.; Avery, M.A.
    Structure-based virtual screening against SARS-3CL(pro) to identify novel non-peptidic hits (2008), Bioorg. Med. Chem., 16, 4138-4149.
    View publication on PubMed

Application

Application Comment Organism
medicine SARS-3CLpro is a viral cysteine protease critical to the life cycle of the pathogen and hence a therapeutic target of importance Severe acute respiratory syndrome-related coronavirus

Inhibitors

Inhibitors Comment Organism Structure
2-[(2-cyclohexylquinazolin-4-yl)sulfanyl]-N-(furan-2-ylmethyl)acetamide 0.01 mM, 30% inhibition Severe acute respiratory syndrome-related coronavirus
3-benzyl-1-[(6,7-dimethyl-2-oxo-1,2-dihydroquinolin-3-yl)methyl]-1-[2-(2-methylphenyl)ethyl]urea 0.01 mM, 40% inhibition Severe acute respiratory syndrome-related coronavirus

Organism

Organism UniProt Comment Textmining
Severe acute respiratory syndrome-related coronavirus
-
-
-

Synonyms

Synonyms Comment Organism
SARS-3CLpro
-
Severe acute respiratory syndrome-related coronavirus

IC50 Value

IC50 Value IC50 Value Maximum Comment Organism Inhibitor Structure
0.0172
-
-
Severe acute respiratory syndrome-related coronavirus 3-benzyl-1-[(6,7-dimethyl-2-oxo-1,2-dihydroquinolin-3-yl)methyl]-1-[2-(2-methylphenyl)ethyl]urea
0.0182
-
-
Severe acute respiratory syndrome-related coronavirus 2-[(2-cyclohexylquinazolin-4-yl)sulfanyl]-N-(furan-2-ylmethyl)acetamide